Alphatec Spine Licenses New Technology to Treat Lumbar Spinal Stenosis

Alphatec Holdings, Inc. announced today that it had entered into a license agreement with Helix Point, LLC, which provides Alphatec Spine with rights to develop and commercialize Helifix and Helifuse, proprietary concepts for two interspinous devices to treat lumbar spinal stenosis (LSS).

IlluminOss Announces First Human Case Utilising Its Innovative Photodynamic Bone Stabilisation System Technology

IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss™ Photodynamic Bone Stabilization System for orthopedic surgery, announced that the first procedure utilizing the IlluminOss Photodynamic Bone Stabilization System had been performed.

CYPHER SELECT® Plus Sirolimus-eluting Coronary Stent Now Approved In The EU For Treatment Of Patients With Diabetes

The CYPHER SELECT®Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union for treatment of patients with diabetes, a complex and often difficult-to-treat patient population.

Edwards Lifesciences Receives CE Mark For New Transfemoral Transcatheter Valve Delivery System

Edwards Lifesciences Corporation announced today that it received CE Mark approval for European commercial sales of the new RetroFlex 3 transfemoral delivery system for the Edwards SAPIEN transcatheter heart valve.

St. Jude Medical Announces U.S. Approval of Industry’s First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices

New lead and cardiac resynchronization system design is expected to offer implanting physicians a simpler and quicker procedure and reduces the volume of the leads and device in the chest pocket for heart failure patients

St. Jude Medical Announces European CE Mark Approval For Libra Deep Brain Stimulation Systems For Parkinson’s Disease

St. Jude Medical, Inc. announced European CE Mark approval of its Libra® and LibraXP™ deep brain stimulation systems for treating the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech.

Cardo Medical Announces the Initial Release of Its Press-Fit Total Hip System

Cardo Medical, a company engaged in the development of orthopedic medical devices, announces the initial release of its Press-Fit Total Hip system. The Press-Fit Total Hip system incorporates a dual taper design which has a long, proven clinical history with great implant success rates.

Flexible Stenting Solutions, Inc. Receives CE Mark for New FlexStent™ Femoropopliteal Self Expanding Stent System

Flexible Stenting Solutions, Inc., a leading developer of next-generation flexible stents, announced today it has received CE Mark for its FlexStent™ Femoropopliteal Self Expanding Stent System.

Isotechnika Announces Full Enrollment Achieved in Partner Atrium’s CONFIRM 1 Trial for Voclosporin Coated Coronary Stent System

Isotechnika Inc. announced today that its partner, Atrium Medical Corporation has completed patient enrollment for their CONFIRM 1, First-in-Man (FIM) drug coated coronary stent clinical trial evaluating Atrium’s CINATRATM voclosporin coated coronary stent system.